Navigation Links
DuPont Provides Technology for Washington Hospital Center's Emergency Department

DuPont Products Help Address Infection Control

WASHINGTON, Jan. 10 /PRNewswire-FirstCall/ -- To help address infection control during everyday hospital operations and minimize risks during times of health crisis, DuPont (NYSE: DD) today announced that one of its healthcare products, DuPont(TM) Corian(R) solid surface, has been selected by the Washington Hospital Center for its emergency department. The product recently was incorporated into a children's ward at the Roswell Park Cancer Institute in Buffalo, N.Y.

Washington Hospital Center is using the technology as part of its vision to build ER One, which will be an all-risks-ready emergency care facility, created to provide emergency medical care during acts of terrorism and emerging illness and built to function fully as a hospital emergency department during daily operations. The current phase of the project, entitled "Bridge to ER One," will test these new innovations and technologies.

"Our DuPont innovations are designed to provide solutions that protect lives," said Thomas F. Schuler, vice president and general manager -- DuPont Building Innovations. "Corian(R) is one of our products that uniquely meets both the stringent safety specifications of the healthcare industry as well as the aesthetic demands of healthcare designers."

The 2006 Guidelines for Design and Construction of Hospital and Healthcare Facilities has defined the 18 preferred characteristics of the ideal healthcare surface to help facilitate improved infection control. Corian(R) meets all 18 of these characteristics, including being nonporous, seamless, durable and not supporting microbial growth when cleaned properly.

"Corian(R) was selected for the Bridge to ER One because it is a seamless, easy-to-clean surface material ideally suited for healthcare environments," said Dr. Mark Smith, chairman of Emergency Medicine at Washington Hospital Center. "There is solid evidence that contaminated surfaces contribute to the spread of infections. Eliminating grout lines and crevices through the use of Corian(R) remove a potential source of microbial contamination from the patient care unit."

DuPont(TM) Corian(R) donated a total of 193 sheets and 17 sinks made of the solid surface material to this phase of the ER One project. Corian(R) was utilized for selected areas of the emergency department, including patient room wall-cladding, nurses' stations surfacing, lobby chair rails, bathroom shower stalls and integrated sinks/vanities.

In conjunction with the Centers for Health Design, Washington Hospital Center will conduct evidence-based research over a two-year period, allowing staffers to test and adjust key elements for the full ER One, which is expected to open in six to 10 years.

Washington Hospital Center is a not-for-profit 926-bed acute care teaching and research hospital based in Northwest Washington. It is the largest private medical center in the nation's capital and among the 25 largest hospitals in the Mid-Atlantic region. The Hospital Center consistently ranks among the nation's top hospitals in the research and treatment of cardiovascular and kidney disease and provides cutting-edge therapies to treat cancer, stroke and acute neurological injury and disease. Washington Hospital Center also is home to MedSTAR Trauma and Transport and is the region's adult burn facility.

DuPont(TM) Corian(R) is a nonporous, high-performing, easy-to-maintain solid surface material that, when properly used or cleaned, does not support the growth of mold or mildew. Non-toxic and non-allergenic to humans, Corian(R) has received NSF/ANSI 51 Certification for food contact and Class 1 (A) fire rating. The American Institute of Architects (AIA) Guidelines for Design and Construction of Hospital and Healthcare Facilities recommends using solid surfacing to help facilitate improved infection control.

Additional DuPont products used in healthcare facilities include:

-- DuPont(TM) Zodiaq(R) quartz surface, to provide an extremely strong,

nonporous material for desks, tables and many other applications;

-- DuPont(TM) Tyvek(R) brand protective material, for sterile medical

packaging, devices and gowns;

-- DuPont(TM) RelyOn(TM) solutions, antiseptics to disinfect, clean and

deodorize a wide range of surfaces;

-- DuPont(TM) Sontara(R), Softesse(R) and Suprel(R) medical fabrics, to

protect and provide comfort for medical personnel and patient gowns,

drapes and wipes;

-- DuPont(TM) Softesse(R) for bandages and other wound care needs;

-- DuPont(TM) Tychem(R) protective garments for emergency room first

responders, and;

-- DuPont(TM) SentryGlas(R) Plus interlayers and SentryGlas(R)

Expressions(TM) decorative interlayers, to provide safety glass that

protects people and buildings and provides high-quality imagery and


DuPont is a science-based products and services company. Founded in 1802, DuPont puts science to work by creating sustainable solutions essential to a better, safer, healthier life for people everywhere. Operating in more than 70 countries, DuPont offers a wide range of innovative products and services for markets including agriculture and food; building and construction; communications; and transportation.

The DuPont Oval, DuPont(TM), The miracles of science(TM), and Corian(R), Zodiaq(R), Tyvek(R), RelyOn(R), Sontara(R), Softesse(R), Suprel(R), Tychem(R), SentryGlas(R) Plus and SentryGlas(R) Expressions(TM) are registered trademarks or trademarks of DuPont or its affiliates.

For more information on DuPont products and services to the medical and healthcare industries, visit:

Photo: Due to length of URL, please cut and paste into browser. pon tNew&Entity=PRAsset&AttachmentType=F&EntityID=108829&AttachmentID=551bf643- b691-4386-8c51-d21302973994&NewWindow=true

Caption: DuPont(TM) Corian(R) is a nonporous, non-toxic and easy-to-clean solid surface material that, when properly used or cleaned, does not support the growth of mold or mildew.

Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Idenix Pharmaceuticals Provides Update on Hepatitis C Pipeline at JP Morgan Healthcare Conference
2. ImaRx Provides Update on TUCSON Phase I/II Clinical Trial in Acute Ischemic Stroke
3. Progen Provides Update on Phase 3 Clinical Program for PI-88 in Liver Cancer
4. IDM Pharma Provides Update of Product Pipeline and Announces Plans to Evaluate Strategic Alternatives for the Company
5. NicOx Completes Enrollment in Second Pivotal Phase 3 Study for Naproxcinod and Provides Development Update
6. Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery
7. Replidyne Provides Strategic Update
8. BioCryst Provides Forodesine HCl Update
9. Celtic Pharma Provides Update on XERECEPT(R) Clinical Program
10. Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference
11. Sinovac Provides Update in Pandemic Influenza Vaccines (H5N1) Phase II Clinical Trials
Post Your Comments:
(Date:10/9/2015)... DIEGO , Oct. 9, 2015 Ansun ... (Infectious Disease Society of America ) regarding the compassionate ... transplant patient on a respirator who was co-infected with ... a five-day course of therapy, O 2 requirement ... the patient was able to go off the respirator ...
(Date:10/8/2015)... October 9, 2015 ® ... diagnostic colonoscopy. The NOCT study also assessed the ... --> ® ) in adult patients ... study also assessed the compliance, safety, patient acceptability ... today announced positive top line results for its ...
(Date:10/8/2015)... PITTSBURGH , Oct. 8, 2015 /PRNewswire/ ... pharmaceutical company, will host a conference call and webcast ... ET to review the value to be created for ... TASE) through Mylan,s offer to acquire the company. During ... outlines the compelling proposition for Perrigo shareholders. Mylan,s offer ...
Breaking Medicine Technology:
... IDEV Technologies, Inc. (IDEV) today announced the firm ... Australia,s regulatory agency for medical drugs and devices, for ... and peripheral procedures. "We are pleased to ... SUPERA VERITAS in the Australian market later this year," ...
... 28, 2011 Onyx Pharmaceuticals, Inc. (Nasdaq: ... evaluating carfilzomib, a selective, next-generation proteasome inhibitor, at the ... Paris, France. "The data we are ... an important new treatment option for patients with multiple ...
Cached Medicine Technology:
(Date:10/10/2015)... , ... October 10, 2015 , ... "I have to walk with crutches for the ... 6.1 million Americans who live this way. Anything that would give me more independence and ... without having to use my hands." , He developed the STRAP IN to enable an ...
(Date:10/10/2015)... ... 10, 2015 , ... Story Chaser is a one-of-a-kind app that ... classics and inspiring stories and as words drop down and users tap the corresponding ... aesthetic and can be interacted with, making it a more engaging game. Users can ...
(Date:10/10/2015)... ... October 10, 2015 , ... Well-known Eastern ... to be recognized by The National Law Journal for inclusion in their second ... firms across the United States who obtained the largest awards for their personal ...
(Date:10/9/2015)... ... October 09, 2015 , ... The American Osteopathic Foundation ... Graduate Medical Education J. Michael Finley, DO, as the recipient of the 2015 ... his impact on graduate medical education opportunities for osteopathic residents, and his dedication ...
(Date:10/9/2015)... , ... October 09, 2015 , ... With the FCPX ... pop grades to footage. A LUT is a Lookup Table that contains a mathematical ... color indicated by the table. This pack comes with 60 vibrant CUBE LUT files. ...
Breaking Medicine News(10 mins):
... mind,s reward centers are less enthused, brain scans find , ... you see your paycheck may have a lot to do ... by researchers at the University of Bonn in Germany. , ... male volunteers divided into pairs. Each pair, in adjoining brain ...
... with a devastating brain injury that has wiped out ... to understand other peoples feelings and intentions, according to ... the Baycrest Centre for Aging and the Brain, and ... The study, published in the Nov. 23, 2007 issue ...
... midday sleepiness, experts say, , , THURSDAY, Nov. 22 (HealthDay ... the Thanksgiving feast aren,t rare, and experts say a ... holiday. , It may have to do with the ... -- a chemical known to promote sleepiness, said Donna ...
... on the future treatment of breast cancer have been identified ... published in the online open access journal Breast Cancer Research ... priorities. , A team led by Professor Mitch Dowsett, ... based in London and Surrey, together with colleagues from the ...
... Health Company,(Amex: FHC ) today announced that it ... Analyst Conference on Wednesday, November 28,2007 at the Princeton ... 5th and,6th). The Company,s CEO, O.B. Parrish, and its ... a.m. Eastern Time (EST)., A "live" webcast of ...
... more ozone, and more strain on hearts, researchers say ... and high ozone levels work together to boost death ... They believe that global warming -- which brings more ... number of people who die of cardiovascular events. , ...
Cached Medicine News:
... (RAM) is the first visual examination device that ... in eyes with glaucoma, cataract, and macular disease. ... test each eye easily in under 60 seconds. ... Columbia University in New York City, the RAM ...
... II Hybrid External Fixation System incorporating ... in hybrid fixation. It incorporates features ... is designed to offer speed of ... Hoffmann® snap-fit technology. , ,Using the ...
... to add individual components for individual indications. ... indications. Made of an innovative composite plastic ... only much lighter. This means it's easier ... comfortable for the patient. ,Come pre-assembled, packaged ...
The Hybrid Fixator consists of Three basic components: rings, wires, clamps. Final fracture reduction can be easily performed after frame assembly....
Medicine Products: